Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.46 |
| ▸ | RAB9A | P51151 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29966674 | 0.80 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL29614829 | 0.80 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL3076524 | 0.80 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL29942654 | 0.80 | NPC1 (0.63) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL713066 | 0.76 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL6097808 | 0.75 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2BCHECYP1A2 | |
| SCHEMBL25712 | 0.74 | MAPT (0.52) | NPC1RAB9ASMN1; SMN2CYP1A2KDM4E | |
| SCHEMBL7976285 | 0.74 | ALDH1A1 (0.37) | NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7972525 | 0.74 | CYP1A2 (0.41) | NPC1RAB9ACYP1A2ALDH1A1 | |
| SCHEMBL4843280 | 0.74 | BCHE (0.30) | BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117024369-A | Multiple host materials and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-8592611-B2 | Trioxane dimer sulfur compounds | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-11-26 | — | — | US | disclosed |
| US-20110124603-A1 | Trioxane Dimer Sulfur Compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124603-A1 | Trioxane Dimer Sulfur Compounds | HCCS, SQOR, SFXN1 | NPC1 3900/4885RAB9A 2333/4885SMN1; SMN2 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.